Oystein fodstad
Oystein fodstad
Professor emeritus, Oslo University Hospital, University of Oslo
Geverifieerd e-mailadres voor rr-research.no
Titel
Geciteerd door
Geciteerd door
Jaar
Tumour exosome integrins determine organotropic metastasis
A Hoshino, B Costa-Silva, TL Shen, G Rodrigues, A Hashimoto, MT Mark, ...
Nature 527 (7578), 329-335, 2015
25522015
Detection and clinical importance of micrometastatic disease
K Pantel, RJ Cote, Ø Fodstad
Journal of the National Cancer Institute 91 (13), 1113-1124, 1999
6571999
Photochemical internalization: a novel technology for delivery of macromolecules into cytosol
K Berg, PK Selbo, L Prasmickaite, TE Tjelle, K Sandvig, J Moan, ...
Cancer research 59 (6), 1180-1183, 1999
5061999
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
AI Riker, SA Enkemann, O Fodstad, S Liu, S Ren, C Morris, Y Xi, P Howell, ...
BMC medical genomics 1 (1), 1-16, 2008
4822008
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition
MF Hansen, A Koufos, BL Gallie, RA Phillips, O Fodstad, A Brøgger, ...
Proceedings of the National Academy of Sciences 82 (18), 6216-6220, 1985
4801985
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression
M Zhou, Z Liu, Y Zhao, Y Ding, H Liu, Y Xi, W Xiong, G Li, J Lu, O Fodstad, ...
Journal of Biological Chemistry 285 (28), 21496-21507, 2010
4282010
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
B Song, Y Wang, Y Xi, K Kudo, S Bruheim, GI Botchkina, E Gavin, Y Wan, ...
Oncogene 28 (46), 4065-4074, 2009
4122009
Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol
M Zhou, Y Zhao, Y Ding, H Liu, Z Liu, O Fodstad, AI Riker, ...
Molecular cancer 9 (1), 1-12, 2010
3102010
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
E Borgen, B Naume, JM Nesland, G Kvalheim, K Beiske, Ø Fodstad, I Diel, ...
Cytotherapy 1 (5), 377-388, 1999
3021999
Significant antitumor effect from bone-seeking, α-particle-emitting 223Ra demonstrated in an experimental skeletal metastases model
G Henriksen, K Breistøl, ØS Bruland, Ø Fodstad, RH Larsen
Cancer research 62 (11), 3120-3125, 2002
2832002
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression
VA Flørenes, S Aamdal, O Myklebost, GM Maelandsmo, ØS Bruland, ...
Cancer research 52 (21), 6088-6091, 1992
2561992
The stem cell‐associated antigen CD133 (Prominin‐1) is a molecular therapeutic target for metastatic melanoma
G Rappa, O Fodstad, A Lorico
Stem cells 26 (12), 3008-3017, 2008
2542008
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer
Y Xi, R Shalgi, O Fodstad, Y Pilpel, J Ju
Clinical cancer research 12 (7), 2014-2024, 2006
2442006
Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites
H Qian, T Wang, L Naumovski, CD Lopez, RK Brachmann
Oncogene 21 (51), 7901-7911, 2002
244*2002
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma
GM Maelandsmo, VA Flørenes, T Mellingsaeter, E Hovig, RS Kerbel, ...
International journal of cancer 74 (4), 464-469, 1997
2411997
Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase‐polymerase chain reaction assays used to detect micrometastatic tumor cells
P Ruud, Ø Fodstad, E Hovig
International journal of cancer 80 (1), 119-125, 1999
2371999
MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status
VA Flørenes, GM Mælandsmo, A Forus, Å Andreassen, O Myklebost, ...
JNCI: Journal of the National Cancer Institute 86 (17), 1297-1302, 1994
2311994
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
AH Ree, VA Florenes, JP Berg, GM Maelandsmo, JM Nesland, O Fodstad
Clinical Cancer Research 3 (9), 1623-1628, 1997
2241997
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti …
K Bjørnland, JO Winberg, OT Ødegaard, E Hovig, T Loennechen, ...
Cancer research 59 (18), 4702-4708, 1999
2131999
Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism
Y Zhao, H Liu, Z Liu, Y Ding, SP LeDoux, GL Wilson, R Voellmy, Y Lin, ...
Cancer research 71 (13), 4585-4597, 2011
2122011
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20